ÂÜÀòÂÒÂ×

Alexandra Brocato is an accomplished investment professional with extensive experience in healthcare and technology sectors. Currently serving as an Investment Professional at General Atlantic since May 2022 and previously as a Summer Analyst for the Healthcare & Life Sciences Teams, Alexandra also holds a fellowship with Birthright Israel Excel. Alexandra has held significant roles in various organizations, including Chief Executive Officer at Simplex Sciences Inc., a biotechnology startup associated with Yale University, and as an Investment Analyst at both Toyota Ventures and OurCrowd. Notably, Alexandra co-founded multiple ventures, such as ADVANCE, an AI-driven nursing communication tool, and Sweet, an online event planning platform. An alumnus of Yale University with a combined BS/MS in Biomedical/Medical Engineering, Alexandra broadened international experience as an exchange student at Università Bocconi.